BioSpace News Archive

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2019 financial results after the market closes on Monday November 4, 2019.

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that the first patient has been dosed in a Phase 2b clinical trial of PB2452,

Kleo Pharmaceuticals Inc. announced that its CEO Doug Manion, M.D., FRCP, will present at the 2019 BIO Investor Forum, which will be held at the Westin St. Francis Union Square in San Francisco on October 22-23rd.

Ziopharm Oncology, Inc., announced that Chris Bowden, M.D., an oncology drug development executive with more than 20 years leadership experience spanning pre-clinical development through commercialization, including the approval of several cancer medicines, has been appointed to the Company’s Board of Directors.

Rapid Acoustic Pulse device granted patents in Taiwan and Japan

Mouse Embryo Assay Provides Proof of Concept Comparing Conventional Dewars and TMRW’s Cryo Robot

Hoth Therapeutics, Inc announced that Robb Knie, Chief Executive Officer, will be presenting at the Dawson James 5th Annual Small Cap Growth Conference which is being held October 28-29, 2019 at the Wyndham Grand Hotel in Jupiter, Florida.

At 5:00 p.m. Eastern Time (ET), senior management will host a conference call to review the Company’s financial performance.

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select over-the-counter and prescription pharmaceutical assets in a number of Near East, Middle East and Africa countries within its Growth and Emerging Markets Business Unit to Acino for a total value in excess of $200 million USD.

The company is scaling its Hawaiian hemp cultivation footprint, introducing a new autoflowering varietal and initiating oil extraction operations on the islands